Treatment of facial asymmetry with poly-L-lactic acid: A case study

Aesthetic Plastic Surgery

Volumn 32, Issue 3, 2008, Pages 552-554

  Burgess, C M ^a  

^a Center for Dermatology and Dermatologic Surgery   (United States)

Author keywords

Case study; Facial augmentation; Poly L lactic acid; Sculptra

Indexed keywords

BOTULINUM TOXIN A; HYALURONIC ACID; POLYLACTIC ACID;

AFRICAN AMERICAN; AGED; ANAMNESIS; ARTICLE; CASE REPORT; FACE ASYMMETRY; FACE MALFORMATION; FACE SURGERY; FACIAL EXPRESSION; FEMALE; HUMAN; MASSAGE; MINIMALLY INVASIVE SURGERY; NOSE RECONSTRUCTION; ORAL SURGERY; PATIENT SATISFACTION; PRIORITY JOURNAL;

AGED; FACIAL ASYMMETRY; FEMALE; HUMANS; LACTIC ACID; POLYMERS;

EID: 44649177146     PISSN: 0364216X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00266-008-9112-3     Document Type: Article

References (20)

1. Amard P, Saint-Marc T, Katz P (2000) The effects of polylactic acid (PLA) as therapy for lipoatrophy of the face. Presented at the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Medscape HIV/AIDS 6(5)
2. Ascher B, Coleman S, Alster T, Bauer U, Burgess C, Butterwick K, Donofrio L, Engelhard P, Goldman MP, Katz P, Vleggaar D (2006) Full scope of effect of facial lipoatrophy: A framework of disease understanding. Dermatol Surg 32:1058-1069
3. Barton SE, Engelhard P, Conant M (2006) Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: A review of the clinical studies. Int J STD AIDS 17:429-435
4. Bergeret-Galley C (2004) Comparison of resorbable soft tissue fillers. Aesth Surg J 24:33-43
5. Burgess CM, Quiroga RM (2005) Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 52:233-239
6. Carr A, Miller J, Law M, Cooper DA (2000) A syndrome of lipoatrophy, lactic acidaemia, and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14:F25-F32
7. Gogolewski S (1992) Resorbable polymers for internal fixation. Clin Mater 10:13-20
8. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK (1993) Tissue response and in vivo degradation of selected polyhydroxyacids: Polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3- hydroxyvalerate) (PHB/VA). J Biomed Mater Res 27:1135-1148
9. James J, Carruthers A, Carruthers J (2002) HIV-associated facial lipoatrophy. Dermatol Surg 28:979-986
10. Kronenthal RL (1975) Biodegradable polymers in medicine. In: Kronenthal RL, Oser Z, Martin E (eds) Polymer Science and Technology. Plenum Press, New York, p 119-137
11. Kulkarni RK, Pani KC, Neuman C, Leonard F (1966) Polylactic acid for surgical implants. Arch Surg 93:839-843
12. Moyle G, Sutinen J (2004) Managing HIV lipoatrophy. Lancet 363:412-414
13. Moyle GJ, Brown S, Lysakova L, Barton SE (2006) Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med 7:181-185
14. Nakamura S, Ninomiya S, Takatori Y, Morimoto S, Kusaba I, Kurokawa T (1993) Polylactide screws in acetabular osteotomy: 28 dysplastic hips followed for 1 year. Acta Orthop Scand 64:301-302
15. Pettit DK, Lawter JR, Huang WJ, Pankey SC, Nightlinger NS, Lynch DH, Schuh JA, Morrissey PJ, Gombotz WR (1997) Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF. Pharm Res 14:1422-1430
16. Sculptra® Product Information, sanofi-aventis, 2006. Retrieved August 2007 at http://www.products.sanofi-aventis.us/sculptra/sculptra.html
17. Spenlehauer G, Veillard M, Benoit JP (1986) Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. J Pharm Sci 75:750-755
18. Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, Bousquet R, Katz P, Costagliola D, Katlama C (2003) Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA. AIDS 17:2471-2477
19. Vleggaar D (2006) Soft tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg 118:46S-54S
20. Vleggaar D, Bauer U (2004) Facial enhancement and the European experience with poly-L-lactic acid. J Drugs Dermatol 3:526-530